Overview of Gynecologic Cancers

Most Common Types: The main types are uterine (endometrial), ovarian, and cervical cancers.

Symptoms: Common warning signs include persistent, unusual vaginal bleeding, pelvic pain, bloating, or lumps in the genital area.

Diagnosis: Often involves pelvic exams, imaging (ultrasound, MRI, PET scans), and tissue biopsies.

Prevention: HPV vaccines and regular screenings (like Pap tests) can help prevent cervical, vaginal, and vulvar cancers.

Ovarian Cancer Research

Key Treatment Options

Treatment depends on the type of cancer, stage, and whether the patient wishes to preserve fertility:

Surgery: Often the first step, especially for early-stage cancers, and can involve removing the uterus (hysterectomy), ovaries/fallopian tubes (salpingo-oophorectomy), or removing as much tumor as possible (debulking/cytoreduction).

Minimally Invasive Surgery (MIS): Laparoscopy or robotic-assisted surgery is now the standard for many early-stage uterine cancers, offering smaller incisions and faster recovery.

Chemotherapy: Used to kill or stop the growth of cancer cells, often as an adjuvant (after surgery) or neoadjuvant (before surgery) to shrink tumors.

Radiation Therapy: Targeted radiation, including external beam or internal (brachytherapy), is used to kill cancer cells, particularly for cervical and vaginal cancers.

Targeted Therapy & Immunotherapy: Newer treatments that focus on specific genetic mutations or enhance the immune system, such as PARP inhibitors for ovarian cancer or checkpoint inhibitors for endometrial/cervical cancers.

Ovarian Cancer Debulking: For advanced ovarian cancer, the goal is "no gross residual tumor," often requiring extensive surgery (debulking) to remove tumors from the bowel or liver surfaces, frequently accompanied by HIPEC (heated intraperitoneal chemotherapy).

Endometrial Cancer: MIS is standard for most, but for high-stage or aggressive non-endometrioid tumors, surgical approaches may differ.

Fertility-Sparing Treatments: For young patients with early-stage disease, conservative treatments (e.g., progestin therapy for uterine cancer, radical trachelectomy for cervical cancer) may be possible.

PARP Inhibitors: These have transformed treatment for ovarian cancer, but recent data has led to restrictions on their use in certain advanced settings